Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04015011 · ClinicalTrials.gov registry record · NA

Effects of a Three-Month Low Calorie Diet Weight Loss Intervention on Knee Replacement Outcomes

A NA study, sponsored by NYU Langone Health.

Terminated
Registry status
NA
Development phase
13
Enrollment target

NCT04015011 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04015011, a NA study, was terminated before completion, sponsored by NYU Langone Health.

TERMINATED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Total Knee Replacement (TKR) significantly improves function, pain, and overall quality of life in patients with end-stage arthritis of the knee. However, studies show that obesity increases complications and costs associated with TKR. The American Academy of Orthopaedic Surgeons (AAOS) clinical guidelines recommend that patients with a BMI \> 25kg/m2 lose 5% of their body weight prior to surgery. Consequently, although it is not clear how to patients or providers achieve weight loss in this population, some providers and hospitals decline to perform TKR in patients with obesity. Low Calorie meal replacement diets (LCD) are a feasible way to safely promote short-term weight loss of 8-15% at 3-6 months prior to some elective surgeries. This is a pilot efficacy study to test whether a short-term program using a 3-month LCD leads to weight loss and improved patient reported and functional outcomes. 75 patients eligible for knee replacement surgery and willing to undergo non-operative weight management treatment at NYU Langone Comprehensive Obesity Center. This study will establish feasibility and weight loss outcomes in preparation for a multicenter effectiveness trial.

Interventions

  • COMBINATION_PRODUCT LCD Intervention

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2019-07-25
Est. Completion 2021-09-30
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04015011

The ClinicalTrials.gov registry entry for NCT04015011 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which LCD Intervention is the first listed.

NCT04015011 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04015011 about?

NCT04015011 is a clinical study titled "Effects of a Three-Month Low Calorie Diet Weight Loss Intervention on Knee Replacement Outcomes". Total Knee Replacement (TKR) significantly improves function, pain, and overall quality of life in patients with end-stage arthritis of the knee. However, studies show that obesity increases complications and costs associated with TKR. The American Academy of Orthopaedic Surgeons (AAOS) clinical gui...

What is the current status of trial NCT04015011?

This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2019-07-25. Estimated completion is 2021-09-30.

What interventions are being tested in trial NCT04015011?

The interventions under investigation include: LCD Intervention (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT04015011?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.